Xilio Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Xilio Therapeutics, Inc. (XLO) had Common Stock, Capital Shares Reserved for Future Issuance of 24.59 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-12
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 24.59M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 24.84M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.47M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 307.62M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 24.59M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 24.84M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 20.47M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 307.62M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 307.59M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 40.97M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 2.70M shares 10-K · filed 2026-03-23 | 37.83M shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 31.28M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 31.29M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 11.34M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 10.16M shares 10-K · filed 2025-03-11 | |
| 2023-09-30 | 10.23M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 10.23M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 10.30M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 8.65M shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 8.38M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 8.38M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 8.38M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 6.73M shares 10-K · filed 2023-03-02 | |
| 2021-09-30 | 22.22M shares 10-Q · filed 2021-12-02 | |
| 2020-12-31 | 8.00M shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |